Clinical trials
Phase 3 Leiomyoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 2 |
| 2006 | 2 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 9 |
| 2018 | 6 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Terminated | 13 |
| Withdrawn | 4 |
| Recruiting | 3 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Repros Therapeutics Inc. | 7 |
| Abbott | 6 |
| Bayer | 6 |
| AbbVie | 4 |
| Myovant Sciences GmbH | 4 |
| PregLem SA | 4 |
| Ain Shams University | 2 |
| Allergan | 2 |
| InSightec | 2 |
| Kissei Pharmaceutical Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leiomyoma | 62 |
| Menorrhagia | 23 |
| Myofibroma | 8 |
| Uterine Hemorrhage | 8 |
| Metrorrhagia | 7 |
| Anemia | 2 |
| Endometriosis | 2 |
| Neoplasms | 2 |
| Uterine Neoplasms | 2 |
| Blood Loss, Surgical | 1 |
Trials
Showing 51 to 62 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.